These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6642143)

  • 21. Genomic DNA analysis of rat retinal tumor induced by adenovirus type 12.
    Kato Y; Matsumoto H; Kobayashi M; Okada Y; Kawaoi A
    Acta Pathol Jpn; 1991 Nov; 41(11):811-7. PubMed ID: 1785341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoptive transfer of immunity to intraocular tumors in mice.
    Niederkorn JY; Streilein JW
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
    Winther JB
    Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoblastoma-like tumors induced in rats by human adenovirus.
    Kobayashi S; Mukai N
    Invest Ophthalmol; 1973 Nov; 12(11):853-6. PubMed ID: 4752925
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophages are vital in spontaneous intraocular tumor eradication.
    Boonman ZF; Schurmans LR; van Rooijen N; Melief CJ; Toes RE; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2959-65. PubMed ID: 16799039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
    Chen PW; Uno T; Ksander BR
    Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterotransplantation of retinoblastoma into the athymic "nude" mouse.
    Gallie BL; Albert DM; Wong JJ; Buyukmihci N; Pullafito CA
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):256-9. PubMed ID: 844983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immunity to a retinoblastoma tissue culture line in patients with retinoblastoma.
    Char DH; Ellsworth R; Rabson AS; Albert DM; Herberman RB
    Am J Ophthalmol; 1974 Jul; 78(1):5-11. PubMed ID: 4835050
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful heterotransplantation of human colon cancer cells to athymic animals is related to tumor cell differentiation and growth kinetics and to host natural killer cell activity.
    Drewinko B; Moskwa P; Lotzovà E; Trujillo JM
    Invasion Metastasis; 1986; 6(2):69-82. PubMed ID: 3700013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cells kill human retinoblastoma cells.
    Ohashi Y; Sasabe T; Nishida T; Manabe R
    Jpn J Ophthalmol; 1984; 28(4):370-6. PubMed ID: 6085129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous immune rejection of intraocular tumors in mice.
    Niederkorn JY; Meunier PC
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of viruses in the pathogenesis of ocular tumors.
    Albert DM; Rabson AS
    Int Ophthalmol Clin; 1972; 12(1):195-224. PubMed ID: 4345548
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of class II antigen-expressing cells in corneal allograft immunity.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2254-60. PubMed ID: 2242991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of cell-mediated immunity in B77 tumor bearing rats by 51chromium release assay.
    Kalafut F; Novotná L; Valentová N
    Neoplasma; 1981; 28(6):689-95. PubMed ID: 7339497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.